The latest update is out from Moleculin Biotech (MBRX).
Moleculin Biotech, Inc. recently conducted a virtual investor call led by Chairman and CEO Walter Klemp, providing insights into the company’s direction and performance. The session is accessible online for those interested in the company’s future prospects. Importantly, the details from this call are for informational purposes and not for official filing or legal incorporation under securities laws.
For a thorough assessment of MBRX stock, go to TipRanks’ Stock Analysis page.
